| [1] |
张永清, 陈丹青, 陈路萍, 等. 基于倾向性评分匹配探讨妊娠早期空腹血清ANGPTL-2及ANGPTL-8水平预测妊娠期糖尿病的价值[J]. 国际妇产科学杂志, 2024, 51(5):536-540. doi: 10.12280/gjfckx.20240680.
|
| [2] |
Champion ML, Battarbee AN, Biggio JR, et al. Postpartum glucose intolerance following early gestational diabetes mellitus[J]. Am J Obstet Gynecol MFM, 2022, 4(3):100609. doi: 10.1016/j.ajogmf.2022.100609.
|
| [3] |
Knudsen LL, Knorr S, Prange SK, et al. Clinical and Metabolic Characterization of Women With Gestational Diabetes Mellitus Within the First Year Postpartum[J]. J Endocr Soc, 2024, 8(6):bvae044. doi: 10.1210/jendso/bvae044.
|
| [4] |
曾晨, 乔虹. 胰岛素样生长因子1、胰岛素生长因子结合蛋白在糖尿病合并结直肠癌中的研究进展[J]. 癌症进展, 2022, 20(9):888-890,893. doi: 10.11877/j.issn.1672-1535.2022.20.09.05.
|
| [5] |
Krishnan HR, Vallerini GP, Gavin HE, et al. Effects of alcohol and PARP inhibition on RNA ribosomal engagement in cortical excitatory neurons[J]. Front Mol Neurosci, 2023, 16:1125160. doi: 10.3389/fnmol.2023.1125160.
|
| [6] |
李桂花, 廖丹, 王玲, 等. 妊娠期糖尿病患者血清PAPP-A、SHBG水平与膳食抗炎指数和产后血糖转归关系[J]. 中国计划生育学杂志, 2023, 31(8):1931-1934,1938. doi: 10.3969/j.issn.1004-8189.2023.08.034.
|
| [7] |
中华医学会妇产科学分会产科学组, 中华医学会围产医学分会妊娠合并糖尿病协作组. 妊娠合并糖尿病诊治指南(2014)[J]. 中华妇产科杂志, 2014, 49(8):561-569. doi: 10.3760/cma.j.issn.0529-567x.2014.08.001.
|
| [8] |
American Diabetes Association. 14. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes-2019[J]. Diabetes Care, 2019, 42(Suppl 1):S165-S172. doi: 10.2337/dc19-S014.
|
| [9] |
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 中华糖尿病杂志, 2021, 13(4):315-409. doi: 10.3760/cma.j.cn115791-20210221-00095.
|
| [10] |
Karavasileiadou S, Almegwely W, Alanazi A, et al. Self-management and self-efficacy of women with gestational diabetes mellitus: a systematic review[J]. Glob Health Action, 2022, 15(1):2087298. doi: 10.1080/16549716.2022.2087298.
|
| [11] |
王红梅, 李锐, 张杰, 等. 不同胰岛素联合二甲双胍对妊娠期糖尿病血清VEGF、ADP、ANGPTL8表达水平的影响[J]. 中国妇产科临床杂志, 2025, 26(1):47-50. doi: 10.13390/j.issn.1672-1861.2025.01.014.
|
| [12] |
Lu W, Hu C. Molecular biomarkers for gestational diabetes mellitus and postpartum diabetes[J]. Chin Med J(Engl), 2022, 135(16):1940-1951. doi: 10.1097/CM9.0000000000002160.
|
| [13] |
Eng PC, Teo AE, Yew TW, et al. Implementing care for women with gestational diabetes after delivery-the challenges ahead[J]. Front Glob Womens Health, 2024, 5:1391213. doi: 10.3389/fgwh.2024.1391213.
|
| [14] |
贺秀萍, 祝玉荣. 孕晚期妊娠期糖尿病患者血清血管粘附蛋白-1和五聚素3表达水平与产后血糖转归的相关性分析[J]. 中国妇幼保健, 2021, 36(18):4190-4194. doi: 10.19829/j.zgfybj.issn.1001-4411.2021.18.014.
|
| [15] |
Pardridge WM. Receptor-mediated drug delivery of bispecific therapeutic antibodies through the blood-brain barrier[J]. Front Drug Deliv, 2023, 3:1227816. doi: 10.3389/fddev.2023.1227816.
|
| [16] |
黄风玲, 杨辰华, 朱翠翠, 等. 基于PI3K/Akt/NF-κB信号通路探讨加味升降散对糖尿病肾病小鼠肾损伤的干预机制[J]. 中医药学报, 2024, 52(1):20-26. doi: 10.19664/j.cnki.1002-2392.240005.
|
| [17] |
黄蕾, 汪燕燕, 孙冉, 等. 人参皂苷Rg1通过抑制MAPK-NLRP1通路减轻2型糖尿病诱导的神经元损伤[J]. 中国药理学通报, 2023, 39(11):2034-2042. doi: 10.12360/CPB202306009.
|
| [18] |
Xie YP, Lin S, Xie BY, et al. Recent progress in metabolic reprogramming in gestational diabetes mellitus: a review[J]. Front Endocrinol(Lausanne), 2023, 14:1284160. doi: 10.3389/fendo.2023.1284160.
|
| [19] |
Raeisi-Dehkordi H, Amiri M, Rathmann W, et al. Sex hormone-binding globulin may explain sex differences for glucose homeostasis and incidence of type 2 diabetes: the KORA study[J]. Eur J Epidemiol, 2024, 39(8):915-924. doi: 10.1007/s10654-024-01136-2.
pmid: 38954350
|
| [20] |
Kumar A, Vanamail P, Gupta RK, et al. Prediction of pre-eclampsia in diabetic pregnant women[J]. Indian J Med Res, 2023, 157(4):330-344. doi: 10.4103/ijmr.IJMR_1594_19.
pmid: 37282396
|
| [21] |
Bizoń A, Franik G, Niepsuj J, et al. The Associations between Sex Hormones and Lipid Profiles in Serum of Women with Different Phenotypes of Polycystic Ovary Syndrome[J]. J Clin Med, 2021, 10(17):3941. doi: 10.3390/jcm10173941.
|
| [22] |
Antonio L, Pauwels S, Laurent MR, et al. Free Testosterone Reflects Metabolic as well as Ovarian Disturbances in Subfertile Oligomenorrheic Women[J]. Int J Endocrinol, 2018, 2018:7956951. doi: 10.1155/2018/7956951.
|
| [23] |
Wang K, Li Y, Chen Y. Androgen excess: a hallmark of polycystic ovary syndrome[J]. Front Endocrinol(Lausanne), 2023, 14:1273542. doi: 10.3389/fendo.2023.1273542.
|
| [24] |
Bhattacharya K, Dey R, Sen D, et al. Polycystic ovary syndrome and its management: In view of oxidative stress[J]. Biomol Concepts, 2024 Jan 19, 15(1). doi: 10.1515/bmc-2022-0038.
|